Pathologically, the STAT1-/- mammary tumors progress from a preneoplastic state classified as mammary intraepithelial neoplasia to adenocarcinoma, mirroring the progression of human breast cancer from atypical hyperplasia to ductal carcinoma in situ and finally to invasive carcinoma. This evidence concerns the gene STAT1 and adenocarcinoma.